T-cell subset composition and functionality in patients with Waldenström's macroglobulinemia

Leuk Lymphoma. 2022 Jun;63(6):1469-1473. doi: 10.1080/10428194.2022.2030478. Epub 2022 Feb 1.

Authors

Karima Amaador¹, Anne Martens^{1

2}, Renate de Boer², Joanne Rietveld², Mirjam Heemskerk³, Caroline E Rutten¹, Eric Eldering^{2

4}, Marie-José Kersten^{1

4}, Arnon P Kater^{1

4}, Josephine Vos^{1

4}, Sanne Tonino^{1

4}

Affiliations

¹ Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
² Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Amsterdam, The Netherlands.
³ Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
⁴ Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.

PMID: 35105260
DOI: 10.1080/10428194.2022.2030478

No abstract available

Publication types

Letter

MeSH terms

Humans
Mutation
Myeloid Differentiation Factor 88 / genetics
T-Lymphocyte Subsets
Waldenstrom Macroglobulinemia* / diagnosis

Substances

Myeloid Differentiation Factor 88